Printed documentation may be ordered separately as PB99-105330.
Documentation is on the diskette.
This product contains text only. Customers must provide their own search and retrieval software. This multicenter Phase III, two are, randomized, blinded trial was designed to evaluate the safety and tolerance of two oral dosing regimens of ZDV administered for 104 weeks to children with HIV infection as defined by specific inclusion criteria. The study was conducted on an outpatient basis. The diskette contains the analysis dataset for ATG-128.